Heterozygous gain-of-function mutations in STAT1 result in immunodeficiency, typically manifesting as chronic mucocutaneous candidiasis (CMC).150 However, a significant proportion of patients (37%) display autoimmune manifestations, including endocrinopathy, autoimmune cytopenia, and SLE. Here, STAT1 is linked to endocrine system disorder.